AU5178999A - Nucleic acid delivery - Google Patents

Nucleic acid delivery

Info

Publication number
AU5178999A
AU5178999A AU51789/99A AU5178999A AU5178999A AU 5178999 A AU5178999 A AU 5178999A AU 51789/99 A AU51789/99 A AU 51789/99A AU 5178999 A AU5178999 A AU 5178999A AU 5178999 A AU5178999 A AU 5178999A
Authority
AU
Australia
Prior art keywords
nucleic acid
acid delivery
delivery
nucleic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51789/99A
Inventor
Ana Maria Rollan Haro
Antony Patrick McHale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gendel Ltd
Original Assignee
Gendel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gendel Ltd filed Critical Gendel Ltd
Publication of AU5178999A publication Critical patent/AU5178999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU51789/99A 1998-07-31 1999-07-30 Nucleic acid delivery Abandoned AU5178999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9816583 1998-07-31
GBGB9816583.0A GB9816583D0 (en) 1998-07-31 1998-07-31 Nucleic acid carrier
PCT/GB1999/002490 WO2000007630A1 (en) 1998-07-31 1999-07-30 Nucleic acid delivery

Publications (1)

Publication Number Publication Date
AU5178999A true AU5178999A (en) 2000-02-28

Family

ID=10836418

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51789/99A Abandoned AU5178999A (en) 1998-07-31 1999-07-30 Nucleic acid delivery

Country Status (3)

Country Link
AU (1) AU5178999A (en)
GB (2) GB9816583D0 (en)
WO (1) WO2000007630A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03000765A (en) * 2000-07-24 2004-05-21 Gendel Ltd Polypeptide delivery ii-2.
WO2002057436A2 (en) * 2001-01-19 2002-07-25 Gendel Limited Red blood cell from a transgenic animal as vehicle for polypeptide delivery
AU2012326203B2 (en) 2011-10-17 2017-11-30 Massachusetts Institute Of Technology Intracellular delivery
WO2015023982A1 (en) 2013-08-16 2015-02-19 Massachusetts Institute Of Technology Selective delivery of material to cells
RU2739794C2 (en) 2014-10-31 2020-12-28 Массачусетс Инститьют Оф Текнолоджи Delivery of biomolecules into cells of immune system
CN107002089B (en) 2014-11-14 2021-09-07 麻省理工学院 Disruption and field-effected delivery of compounds and compositions into cells
CA2971626A1 (en) 2015-01-12 2016-07-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
CA2988996A1 (en) * 2015-07-09 2017-01-12 Massachusetts Institute Of Technology Delivery of materials to anucleate cells
WO2017041051A1 (en) 2015-09-04 2017-03-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931276A (en) * 1987-10-30 1990-06-05 Franco Robert S Method for introducing desired agents into red blood cells
AU6505690A (en) * 1989-09-26 1991-04-28 Richard R Behringer Erythroid-specific gene expression system
CA2150617C (en) * 1995-02-07 2001-10-30 Universite Laval Nanoerythrosome as bioactive agent carrier

Also Published As

Publication number Publication date
GB2350060A (en) 2000-11-22
WO2000007630A1 (en) 2000-02-17
GB0017761D0 (en) 2000-09-06
GB9816583D0 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
AU6629200A (en) Alpha-helical peptide nucleic acid alpha-pna
AU1115200A (en) Nucleic acid arrays
AU4307997A (en) Nucleic acid particle delivery
AU3849999A (en) Endo-beta-n-acetylglucosaminidase gene
AUPQ262599A0 (en) Gene expression
AU8234898A (en) Characterising nucleic acid
AU5178999A (en) Nucleic acid delivery
AU7813698A (en) Nucleic acid detection
AU6417799A (en) Matrix-remodeling genes
AU2376200A (en) Insulin-synthesis genes
AU8234798A (en) Categorising nucleic acid
AU5377599A (en) Nucleic acids
AU5370696A (en) Egf-targeted nucleic acid delivery
AU6871900A (en) Tsg-like gene
AU1870000A (en) Gene therapy-2
AUPP964899A0 (en) Constructional system
AU4513599A (en) Nucleotide sequence
AU3895499A (en) Methods and compositions for nucleic acid delivery
AU5314999A (en) Modified oligonucleotides
AUPP058797A0 (en) Novel gene
AU3991099A (en) Human nucleic acid methylases
AU2003202523A1 (en) Nucleic acid delivery vehicles
AU5494700A (en) Rna metabolism proteins
AU4107500A (en) Nucleic acid combination
AUPP704498A0 (en) Nucleic acid sequence

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase